Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

NCT00257686 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 962

Last updated 2010-03-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of pravastatin in elderly patients

Conditions

  • Hypercholesterolemia or Combined Dyslipidemia

Interventions

DRUG

Pitavastatin

DRUG

Pravastatin

Sponsors & Collaborators

  • Kowa Research Europe

    lead INDUSTRY

Principal Investigators

  • Dragos Budinski, MD · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • Denmark
  • Germany
  • Israel
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257686 on ClinicalTrials.gov